Central nervous system disordersDisease2 papersLatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 0Oct 2026: 03 in 12 monthsMolecular Biology Reports·10 AugSemaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunitiesReviewSemaglutidePaperAgeing Research Reviews·9 AugMetabolic reprogramming-driven neuroimmunoregulation: Key mechanisms and therapeutic opportunities and challenges in central nervous system disordersReviewAmino acid metabolismPaperAging and Disease·26 FebAging of the Blood-Brain Barrier and Altered Permeability to Peripheral Immune Cells: Implications for Central Nervous System DisordersReviewImmune responsePaper
Molecular Biology Reports·10 AugSemaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunitiesReviewSemaglutidePaper
Ageing Research Reviews·9 AugMetabolic reprogramming-driven neuroimmunoregulation: Key mechanisms and therapeutic opportunities and challenges in central nervous system disordersReviewAmino acid metabolismPaper
Aging and Disease·26 FebAging of the Blood-Brain Barrier and Altered Permeability to Peripheral Immune Cells: Implications for Central Nervous System DisordersReviewImmune responsePaper